Chikungunya
Chikungunya
IXCHIQ
One dose, only after a travel-health assessment. Every product below is a Health Canada authorized vaccine; every schedule comes from the Canadian Immunization Guide.
Products authorized in Canada
Brand names and DINs (Drug Identification Numbers) as Health Canada's Drug Product Database lists them. The product monograph is the manufacturer's full prescribing information approved by Health Canada.
| Product | DIN | What it is | Presentation and age | Official information |
|---|---|---|---|---|
| IXCHIQ Live vaccine | 02548984 | Chikungunya virus, live attenuated | 0.5 mL · powder for solution · intramuscular · authorized from 12 years; not recommended at 65 and older | Product guideHealth Canada recordProduct monograph (PDF) |
Pregnancy and breastfeeding
Pregnancy
Generally contraindicated: a live vaccine. Avoid pregnancy for one month after vaccination.
Breastfeeding
Limited data; an individual assessment with a healthcare provider.
Source: Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026. Live vaccines are generally contraindicated in pregnancy; routinely recommended vaccines can be given while breastfeeding unless the chapter says otherwise.
How many doses
The schedules the Canadian Immunization Guide describes for this vaccine. Which one applies depends on age, health and product — use the dose planner to see the dates for your situation.
| Schedule | Doses | Who it is for | Products |
|---|---|---|---|
| Chikungunya (IXCHIQ) — adults 18 to 64, one dose after a travel-health assessment One dose of live chikungunya vaccine; not routinely recommended, considered only for people at high risk of exposure. | 1 dose | CATMAT: IXCHIQ is generally not recommended for adults 18 to 64 years of age but may be considered for individuals at high risk of infection; it is not recommended at 65 years of age and older (serious adverse events, including deaths, reported mostly in older adults). Health Canada authorizes it from 12 years. Contraindicated in pregnancy and with a weakened immune system. | IXCHIQ |
Sources
- Chikungunya vaccine: Canadian Immunization Guide — Chapter published February 2026 · updated July 2026
- Health Canada Drug Product Database — product records and monographs
Clinical rules reviewed on 2026-09-27. General information from public Canadian guidance; a personal assessment is needed for treatment decisions. Care365 does not decide whether a vaccine is publicly funded in Ontario.